Financial results Q3: Sun Pharma Q3 profit slides 75% to Rs365 crore on weak US sales

India’s largest drugmaker Sun Pharmaceutical Industries Ltd reported a 75% plunge in third-quarter net profit on Wednesday as pricing pressures in the United States, its biggest market, hit sales.

Financial results:Torrent Pharmaceuticals Q3 net profit at Rs 20 crore

Torrent Pharmaceuticals today registered a major dip in the net profit for the quarter ended December 2017 at Rs 20 crore due to 14 per cent fall in the US business.

The company had reported the net profit of Rs 234 crore in the same period last year.

financial results Q3: Alkem net declines by 23.4% as tax provision moved up, interim dividend of 300%

Alkem Laboratories, a Rs.5,850 crore plus pharma major, has reported lower consolidated net profit of Rs.180.87 crore during the third quarter ended December 2017 from Rs.236.26 crore in the corresponding period of last year due to one-off charge of Rs.44.90 crore on account of significant changes to the US corporate income tax system. Its tax provision went up sharply to Rs.151.54 crore

Financial results:Glenmark Pharma Q3 profit falls 78% to Rs104.7 crore

Glenmark Pharmaceuticals on Thursday said its net profit dropped 78% to Rs104.7 crore for the quarter ended December on sharp decline of US sales, despite growth in domestic formulations as well as other geographies.

Financial results:Taro Pharma net dips by 87% to US$ 18 million in Q3

Taro Pharmaceutical Industries has suffered major setback during the third quarter ended December 2017 and its net profit declined sharply by 87.1 per cent to $18 million from $139.8 million in the similar period of last

Financial results:Cadila Healthcare Q3 net profit rises 68% to Rs 543 crore

Cadila Healthcare today reported 67.73 per cent rise in consolidated net profit at Rs 543.3 crore for the third quarter ended December 31.

Financial results:Ipca Laboratories net profit jumps by 158% in Q3 to Rs.106 crore

Ipca Laboratories, a Rs.3,150 crore plus Mumbai based pharma major, has posted impressive growth in standalone net profit of 158 per cent during the third quarter ended December 2017 to Rs.106 crore from Rs.41 crore in the

Financial results:Cipla Q3 profit rises about 7% to Rs401 crore

 Cipla Ltd, India’s fourth-largest drugmaker by revenue, said third-quarter net profit rose 7% on strong domestic sales, but fell short of analysts’ estimates.

Financial results Q3:Aurobindo Pharma may post 18% growth in Q3 profit, US business seen up 12%

Healthcare company Aurobindo Pharmais expected to report a 18 percent growth year-on-year in third quarter profit at Rs 682 crore compared to Rs 578.6 crore in year-ago.

Financial results Q3:Lupin net plunges 65% in Q3

Pharma major Lupin Ltd on Tuesday reported a whopping 65 per cent annual decline in consolidated net profit to Rs 222 crore for the third quarter of 2017-18 from Rs 633 crore in the same period year ago.

Financial results: Natco Pharma Q3 net profit up 12% at Rs 217.4 cr

Drug firm Natco Pharma today reported a 11.54 per cent rise in its consolidated profit after tax at Rs 217.4 crore for the quarter ended December 2017.

Deal: Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs

Brazilian drugs firm EMS and Indian rivalTorrent Pharmahave emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources familiar with the matter told Reuters.

Financial results Q3:GlaxoSmithKline Pharma net jumps by 69% in Q3

GlaxoSmithKline Pharmaceuticals (GSK), a Rs.2,990 crore plus pharma MNC, has posted impressive growth in net profit during the third quarter ended December 2017 and its net profit went up by 69.4 per cent to Rs.89.69 crore from Rs.52.95 crore in the corresponding period of last year. Profit Before Tax (PBT) at Rs.140

Financial results Q3: GlaxoSmithKline Pharma Q3 profit up 69% at Rs89 crore

Drug firm GlaxoSmithKline Pharmaceuticals on Friday reported a 69.38% rise in its standalone net profit to Rs89.69 crore for the quarter ended December 2017.

Financial results:Roche reports good results in 2017

In 2017, Group sales rose 5% to CHF 53.3 billion. Core operating profit grew 3% and Core EPS increased 5%, reflecting the good underlying business performance. On an IFRS basis net income

Financial results Q3: Neuland Laboratories net dips by 66.7% in Q3

Neuland Laboratories, a Rs.575 crore pharmaceutical company from Hyderabad, has suffered a major setback during the third quarter ended December 2017 and its net profit declined by 66.7 per cent to Rs.1.21 crore from Rs.3.63 crore in the corresponding period of last year. Its net sales also declined by 13.9 per cent to Rs.115.93 crore from Rs.134.60 crore. With lower profits, EPS declined to Rs.1.36 from Rs.4.09 in the last period.  

Budget inside: Healthcare industry welcomes Union Budget 2018

The healthcare industry in the country has hailed the Union Budget presented in Parliament today by Finance Minister Arun Jaitly. 

Financial results Q3:Alembic Pharma net profit rises 52% to Rs 131 crore

Drug firm Alembic Pharmaceuticals today reported a 52.32 per cent jump in its consolidated net profit to Rs 131 crore for the third quarter ended December 31, on account of robust sales.

Financial results:SPARC registers net loss of Rs. 58 cr in Q3

Sun Phama Advanced Research Company (SPARC), has suffered another setback during the third quarter ended December 2018 and its net loss amounted to Rs.58.07 crore as against Rs.66.02 crore in the corresponding period of last year.

Divi's Laboratories net dips by 16% in Q3 to Rs. 225 crore

Divi's Laboratories, a Rs. 4,000 crore pharma giant from Hyderabad, has suffered a setback during the third quarter ended December 2017 and its net profit declined by 16.3 per cent to Rs. 225 crore from Rs. 268 crore in the corresponding period of last year.